Martínez-Gutiérrez M

Language: Spanish
References: 9
Page: 409-410
PDF size: 104.35 Kb.

Text Extraction

No abstract.

REFERENCES

1. Osorio L, Ramirez M, Bonelo A, Villar LA, Parra B. Comparison of the diagnostic accuracy of commercial NS1-based diagnostic tests for early dengue infection. Virol J 2010; 7: 361.

2. Diaz-Quijano FA, Villar-Centeno LA, Martinez- Vega RA. Reducción de la hospitalización mediante un algoritmo de manejo del dengue en Colombia. Rev Panam Salud Publica 2011; 30: 248-254.

3. Falconar AK, Romero-Vivas CM. Simple prognostic criteria can definitively identify patients who develop severe versus non-severe dengue disease, or have other febrile illnesses. J Clin Med Res 2012; 4: 33-44

4. Arboleda S, Jaramillo ON, Peterson AT. Spatial and temporal dynamics of Aedes aegypti larval sites in Bello, Colombia. J Vector Ecol 2012; 37: 37-48.

5. Ocampo CB, Salazar-Terreros MJ, Mina NJ, McAllister J, Brogdon W. Insecticide resistance status of Aedes aegypti in 10 localities in Colombia. Acta Trop 2011; 118: 37-44.

6. Cadavid-Restrepo G, Sahaza J, Orduz S. Treatment of an Aedes aegypti colony with the Cry11Aa toxin for 54 generations results in the development of resistance. Mem Inst Oswaldo Cruz 2012; 107: 74-79.

7. Ocazionez RE, Meneses R, Torres FA, Stashenko E. Virucidal activity of Colombian Lippia essential oils on dengue virus replication in vitro. Mem Inst Oswaldo Cruz 2010; 105: 304-309.

8. Martinez-Gutierrez M, Castellanos JE, Gallego- Gomez JC. Statins reduce dengue virus production via decreased virion assembly. Intervirology 2011; 54: 202-216.

9. Salgado D, Zabaleta TE, Hatch S, Vega MR, Rodriguez J. Use of pentoxifylline in treatment of children with dengue hemorrhagic fever. Pediatr Infect Dis J 2012;31: 771-3.